Do GLP1s cause pancreatitis?
I ran the systematic review and meta-analysis: 31 RCTs with 40,274 patients
Results:
Placebo — 50 cases/17433 patients
GLP1 (Semaglutide or Tirzepatide) — 59 cases/22841 patients
OR 0.99 (95% CI 0.67-1.45)
Conclusion: There's no obvious pancreatitis safety signal in these pooled randomized data, but the overall incidence of acute pancreatitis was very very low
Today we're launching the world's first AI-native systematic review platform.
We made it for researchers in academia, medicine, and pharma.
Search, screening, data extraction, risk of bias, and analysis – in hours, not months.
Try it now at https://t.co/3LnG8wrgK4
@JaicSam@DrSamuelBHume We're in the process of integrating this- out of curiosity are there any parts of the review process you'd specifically want to use the api for?
If you run systematic reviews in academia, biotech, or pharma, we built a new platform that'll help you do the end-to-end workflow — in minutes to hours
Try it for free here: https://t.co/5zPgHlfmTb